These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9330921)

  • 21. Monitoring in methadone maintenance treatment.
    Baker JG; Rounds JB; Carson CA
    Int J Addict; 1995 Jul; 30(9):1177-85. PubMed ID: 7591356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving treatment engagement and outcomes for cocaine-using methadone patients.
    Villano CL; Rosenblum A; Magura S; Fong C
    Am J Drug Alcohol Abuse; 2002; 28(2):213-30. PubMed ID: 12014813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with lapses to heroin use during methadone maintenance.
    Wasserman DA; Weinstein MG; Havassy BE; Hall SM
    Drug Alcohol Depend; 1998 Nov; 52(3):183-92. PubMed ID: 9839144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
    Schäfer I; Eiroa-Orosa FJ; Verthein U; Dilg C; Haasen C; Reimer J
    Psychopathology; 2010; 43(2):88-95. PubMed ID: 20068379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
    Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance program.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1982 Dec; 10(4):383-91. PubMed ID: 7166147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Subjective wellbeing and somatic markers in methadone substitution. Evaluation of 61 heroin addicts].
    Giacomuzzi SM; Riemer Y; Kemmler G; Ertl M; Richter R; Rössler H; Hinterhuber H
    Fortschr Med Orig; 2001 Nov; 119(3-4):103-8. PubMed ID: 11789120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China.
    Chen W; Li X; Li X; Ling L; Xia Y; Chen J; He Q
    J Addict Med; 2012 Sep; 6(3):212-8. PubMed ID: 22614937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychodynamic aspects of treatment of heroin dependent patients with methadone substitution].
    Scherbaum N; Heigl-Evers A
    Psychother Psychosom Med Psychol; 1996 Feb; 46(2):47-51. PubMed ID: 8851065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients.
    Schmitz JM; Rhoades H; Grabowski J
    Addict Behav; 1995; 20(2):171-9. PubMed ID: 7484311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 Study.
    Schifano F; Martinotti G; Cunniff A; Reissner V; Scherbaum N; Ghodse H
    Am J Addict; 2012; 21(3):268-73. PubMed ID: 22494230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of heroin addicts with methadone. Concept of a polarization of therapy (author's transl)].
    Gmür M
    Psychiatr Prax; 1981 May; 8(2):54-9. PubMed ID: 7244047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial expressed emotion among heroin addicts in methadone maintenance treatment: does it matter?
    Lee CH; Wang TJ; Tang HP; Liu YH; Bell J
    Addict Behav; 2015 Jun; 45():39-44. PubMed ID: 25638535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.